{"schema_version":"secwatch.filing_event.v1","accession":"0001639691-24-000016","form_type":"8-K","ticker":"LIVN","cik":"0001639691","company_name":"LivaNova PLC","filed_at":"2024-02-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.941267+00:00","generated_at":"2026-06-05T22:07:30.889234+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"LivaNova Q4 revenue $310M (+12.8%), adj. EPS $0.87; full-year $1.15B; new CEO","bullets":["Q4 revenue $310.1M, up 12.8% reported (11.9% constant currency) vs prior year.","Q4 GAAP diluted EPS $0.30; adjusted diluted EPS $0.87.","Full-year 2023 revenue $1.15B, up 12.9% reported (13.3% constant currency).","Full-year GAAP diluted EPS $0.32; adjusted diluted EPS $2.80, up 17% YoY.","Board named Vladimir A. Makatsaria CEO effective March 1, 2024; winding down Advanced Circulatory Support segment."],"urls":{"canonical":"https://secwatch.observer/filing/0001639691-24-000016","json":"https://secwatch.observer/filing/0001639691-24-000016.json","markdown":"https://secwatch.observer/filing/0001639691-24-000016.md","text":"https://secwatch.observer/filing/0001639691-24-000016.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1639691/000163969124000016/0001639691-24-000016-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1639691/000163969124000016/livn-20240221.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T22:07:30.889234+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"21e3a87f91fe7c8109c2d01d784f0fb5d55eb2d3","claim":"LivaNova PLC reported quarter and full year ended December 31, 2023 results: revenue $310.1 million, EPS $0.30. Guidance initiated.","evidence_excerpt":"Financial Summary and Highlights 1 • Fourth-quarter revenue of $310.1 million increased 12.8 percent on a reported basis and 11.9 percent on a constant-currency basis, as compared to the prior-year period • Fourth-quarter U.S.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1639691/000163969124000016/0001639691-24-000016-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"quarter and full year ended December 31, 2023"},{"label":"Revenue","value":"$310.1 million"},{"label":"EPS","value":"$0.30"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}